These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
108 related articles for article (PubMed ID: 17569153)
1. Fecal tumor M2 pyruvate kinase is not a specific biomarker for colorectal cancer screening. Shastri YM; Stein J World J Gastroenterol; 2007 May; 13(19):2768-9. PubMed ID: 17569153 [No Abstract] [Full Text] [Related]
2. New faecal tests for colorectal cancer screening: is tumour pyruvate kinase M2 one of the options? Shastri YM; Stein JM Br J Cancer; 2007 Dec; 97(11):1595-6; author reply 1597. PubMed ID: 17955052 [No Abstract] [Full Text] [Related]
3. Colorectal cancer detection in an asymptomatic population: fecal immunochemical test for hemoglobin vs. fecal M2-type pyruvate kinase. Caviglia GP; Cabianca L; Fagoonee S; Gili FM Biochem Med (Zagreb); 2016; 26(1):114-20. PubMed ID: 26981025 [TBL] [Abstract][Full Text] [Related]
4. Prospective multicenter evaluation of fecal tumor pyruvate kinase type M2 (M2-PK) as a screening biomarker for colorectal neoplasia. Shastri YM; Naumann M; Oremek GM; Hanisch E; Rösch W; Mössner J; Caspary WF; Stein JM Int J Cancer; 2006 Dec; 119(11):2651-6. PubMed ID: 16929517 [TBL] [Abstract][Full Text] [Related]
5. Colorectal cancer screening by non-invasive metabolic biomarker fecal tumor M2-PK. Tonus C; Neupert G; Sellinger M World J Gastroenterol; 2006 Nov; 12(43):7007-11. PubMed ID: 17109496 [TBL] [Abstract][Full Text] [Related]
6. [Faecal pyruvate kinase type M2--a valid screening parameter for colorectal cancer? Preliminary results from a multicenter comparative study]. Naumann M; Schaum B; Oremek GM; Hanisch E; Rösch W; Mössner J; Caspary WF; Stein J Dtsch Med Wochenschr; 2004 Aug; 129(34-35):1806-7. PubMed ID: 15314744 [No Abstract] [Full Text] [Related]
7. Faecal tumour pyruvate kinase M2: not a good marker for the detection of colorectal adenomas. Shastri YM; Stein JM Br J Cancer; 2008 Oct; 99(8):1366; author reply 1367. PubMed ID: 18827821 [No Abstract] [Full Text] [Related]
8. Fecal pyruvate kinase concentrations (ELISA based on a combination of clone 1 and clone 3 antibodies) for gastric cancer screening. Hardt PD; Toepler M; Ngoumou B; Rupp J; Kloer HU Anticancer Res; 2003; 23(2A):855-7. PubMed ID: 12820313 [TBL] [Abstract][Full Text] [Related]
9. The Usefulness of a Novel Screening Kit for Colorectal Cancer Using the Immunochromatographic Fecal Tumor M2 Pyruvate Kinase Test. Kim YC; Kim JH; Cheung DY; Kim TH; Jun EJ; Oh JW; Kim CW; Chung WC; Kim BW; Kim SS; Kim JI; Park SH; Kim JK Gut Liver; 2015 Sep; 9(5):641-8. PubMed ID: 25473070 [TBL] [Abstract][Full Text] [Related]
10. [Clinical significance of blood and fecal tumor M2-pyruvate kinase expression in patients with colorectal cancer]. Li Y; Wang JJ Nan Fang Yi Ke Da Xue Xue Bao; 2011 Dec; 31(12):2087-9. PubMed ID: 22200720 [TBL] [Abstract][Full Text] [Related]
11. [Pyruvate kinase M2 (tumor M2-PK) as a screening tool for colorectal cancer (CRC). A review of current published data]. Ewald N; Toepler M; Akinci A; Kloer HU; Bretzel RG; Hardt PD Z Gastroenterol; 2005 Dec; 43(12):1313-7. PubMed ID: 16315127 [TBL] [Abstract][Full Text] [Related]
12. Evaluation of the Performance of a Fecal Tumor M2-PK Rapid Kit Using Stool Specimens for Detection of Colorectal Tumors. Cho CH; Kim J; Jang MA; Lee BJ; Park JJ; Lim CS Ann Clin Lab Sci; 2016; 46(2):154-60. PubMed ID: 27098621 [TBL] [Abstract][Full Text] [Related]
13. Fecal pyruvate kinase-M2 (tumor M2-PK) measurement: a new screening concept for colorectal cancer. Ewald N; Schaller M; Bayer M; Akinci A; Bretzel RG; Kloer HU; Hardt PD Anticancer Res; 2007; 27(4A):1949-52. PubMed ID: 17649802 [TBL] [Abstract][Full Text] [Related]
15. The Diagnostic Accuracy of the M2 Pyruvate Kinase Quick Stool Test--A Rapid Office Based Assay Test for the Detection of Colorectal Cancer. Sithambaram S; Hilmi I; Goh KL PLoS One; 2015; 10(7):e0131616. PubMed ID: 26158845 [TBL] [Abstract][Full Text] [Related]
16. The value of fecal tumor M2 pyruvate kinase as a diagnostic tool for colorectal cancer screening. Abdullah M; Rani AA; Simadibrata M; Fauzi A; Syam AF Acta Med Indones; 2012 Apr; 44(2):94-9. PubMed ID: 22745138 [TBL] [Abstract][Full Text] [Related]
17. Tumor M2 pyruvate kinase: a tumor marker and its clinical application in gastrointestinal malignancy. Hardt PD; Ewald N Expert Rev Mol Diagn; 2008 Sep; 8(5):579-85. PubMed ID: 18785806 [TBL] [Abstract][Full Text] [Related]
18. Sensitivity and specificity of faecal tumour M2 pyruvate kinase for detection of colorectal adenomas in a large screening study. Haug U; Hundt S; Brenner H Br J Cancer; 2008 Jul; 99(1):133-5. PubMed ID: 18542075 [TBL] [Abstract][Full Text] [Related]
19. [Pilot study on M2-PK-- a new non-invasive parameter for early diagnosis of colorectal carcinoma]. Ivanova A; Iarŭmov N; Toshev S; Adzharov D; Krŭstev Z; Angelov K; Sokolov M; Gribnev P Khirurgiia (Sofiia); 2007; (6):5-7. PubMed ID: 18622373 [TBL] [Abstract][Full Text] [Related]
20. Tumor M2 pyruvate kinase as a stool marker for colorectal cancer: stability at room temperature and implications for application in the screening setting. Haug U; Wente MN; Seiler CM; Rothenbacher D; Büchler MW; Brenner H Clin Chem; 2006 Apr; 52(4):782-4. PubMed ID: 16595841 [No Abstract] [Full Text] [Related] [Next] [New Search]